Inhibition of an enzyme that promotes inflammation may reduce cardiovascular risk in obese people

A research team led by Dr. Martin Mollenhauer from the Heart Center at University Hospital Cologne has investigated the link between obesity and the risk of cardiovascular disease in greater detail. The researchers have discovered that in obese patients and in mouse models, increased levels of the oxidative enzyme myeloperoxidase (MPO) are associated with poorer vascular function.